Searched for
SOMERSET INDUS CAPITAL
PE firm Somerset Indus closes $288 million Fund III, beats targetSomerset Indus Capital Partners closed its third fund at $288 million, exceeding targets, to invest in affordable healthcare across India. ...- PE-firm InvAscent buys out Somerset, invests Rs 265 Cr in Rajasthan-based hospital chain ApexLife sciences private equity firm InvAscent has acquired a significant stake in Apex Hospitals, investing $30 million (Rs 265 crore). This ...
- PE fund Somerset picks up minority stake in Cyrix Healthcare for Rs 140 croreThis transaction is expected to strengthen Cyrix’s presence in the equipment servicing space. Both primary and secondary capital was involv...
- General Atlantic buys hospital chain Ujala CygnusGeneral Atlantic acquires Ujala Cygnus for Rs1600 crore, with existing investors exiting fully. Ujala Cygnus to enhance infrastructure and ...
- General Atlantic set to acquire Amar Ujala's hospital chain Cygnus HealthcareGA will acquire about 51% stake held by existing investors - Eight Roads Ventures India, Evolvence India Fund and Somerset Indus Healthcare...
- Emil raises Rs 150 cr from Somerset Indus Capital"The investment is through a mix of primary (Rs 120 crore) and secondary (Rs 30 crore) sale," said Tushar Korday director, Emil Pharmaceuti...
- Ujala Cygnus to raise Rs 150 crore from PE investorsUjala Cygnus is controlled by leading media house Amar Ujala through its healthcare arm Medicive Healthcare. Ghoshal owns 25% in Medicive. ...
- GenWorks secures Rs 135 crore funding in the latest roundThe fragmented healthcare system has been under pressure, amplified by the Covid pandemic. Chronic care and elective surgeries took a beati...
- Hexagon Nutrition gets Sebi's nod to garner Rs 600-cr via IPOHexagon Nutrition, which filed preliminary IPO papers with Sebi in December 2021, obtained its observations letter on March 4 2022, an upda...
- Hexagon Nutrition files IPO papers to raise up to Rs 600 crThe company's public issue consists of a fresh issue of equity shares aggregating to Rs 100 crore, and an offer for sale (OFS) of up to 30,...
- Krsnaa Diagnostics IPO to open on August 4; price band set at Rs 933-954/shareThe three-day initial public offer (IPO) will open for public subscription on August 4 and conclude on August 6. The bidding for anchor inv...
- Krsnaa Diagnostics files papers for Rs 1,200 crore IPOFor the financial year ended March 31, 2020, the company's total income came in at Rs 271.38 crore as against Rs 214.31 crore for the previ...
- Stempeutics: The startup which uses donor stem cells to treat peripheral artery diseaseAnother company which works in a similar space in India include Kasiak Research, which is a part of Bharat Serums and Vaccines (BSVL).
- Investors feel the pulse of online pharma potentialVCs aim to close multiple deals despite a lack of clarity on regulatory issues in the segment
- Core Diagnostics scores Rs 84 crore in fresh funding in round led by Fidelity investment armsProceeds from the Series B round of funding, which also saw participation from existing investor Artiman Ventures, will be used by the Gurg...
- ChrysCapital exits Mankind, sells 11% stake to Capital International for $200 millionMankind has been growing at a compounded annual growth rate of 20% for the last five years, with revenues touching Rs 3,500 crore in year e...
- Cygnus Hospitals aims to have 50 units by March 2018Cygnus Hospitals, which operates a chain of super speciality units in Delhi and Haryana, aims to add another 40 hospitals in north India.
- India Life Sciences Fund II to invest Rs 92 crore in CPO & Relisys Medical DevicesBoth deals are fairly unique according to industry trackers, who said that these segments have not attracted sizeable capital due to factor...
- Fidelity leads Rs 60 crore investment in Delhi-based healthcare chain Cygnus MedicareCygnus, whose promoters are four doctors, merged with Altius Healthcare in early 2013. The company reported revenues of Rs 68 crore in 2013...
- Somerset Indus Capital Partners buys minority stake in Prognosys & ChayagraphicsSomerset Capital's first fund, which raised $27 million (Rs 160 crore) is backed by US buyout firm Avista Capital and Health Evolution Part...
Load More
